IntraOsseous BioPlasty® (IOBP®) Procedure
A biologic solution for subchondral bone damage
.webp)
Support Joint Preservation at the Base
Encouraging physiologic bone remodeling and repair, the IOBP procedure achieves core decompression of lesions and delivers a concentrated dose of platelet-rich plasma (cPRP) from bone marrow aspirate (BMA) using the Angel® system mixed with AlloSync™ Pure demineralized bone matrix.
The biologic material delivered to the subchondral bone contains the necessary components to aid bone repair: an osteoconductive scaffold, osteoinductive factors, and an osteogenic source of stem cells.1
The IOBP technique is associated with clinically significant improvements in pain and function,2 and can be integrated with treatments for concomitant pathologies, supporting joint preservation in patients.
AlloSync Pure DBM can be mixed with concentrated BMA from the Angel system
Scientific Support for the IOBP Procedure
The IOBP procedure has a low complication rate and allows patients an early return to function and activities of daily living.3,4 Additionally, this minimally invasive joint preservation technique can help delay more invasive procedures, such as total joint arthroplasty.5
Reimbursement and Claims Guidance
Arthrex supports surgeons through comprehensive reimbursement and claims support, including product-specific information about coding and billing scenarios that may be used for procedures that employ our products.
Note: Information contained in this reimbursement guide is for educational and strategic planning purposes only.
